Successful treatment of refractory endometriosis-related chronic pelvic pain with aromatase inhibitors in premenopausal patients

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 143, Issue 2, 2009, Pages 112-115

  Verma, Alka ^a   Konje, Justin C ^b  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Aromatase inhibitors; Endometriosis; Pelvic pain

Indexed keywords

ALENDRONIC ACID; ANASTROZOLE; AROMATASE INHIBITOR; CALCIUM; ESTRADIOL; FOLLITROPIN; LETROZOLE; LUTEINIZING HORMONE; NORETHISTERONE ACETATE; VITAMIN D;

ADULT; ARTHRALGIA; ARTICLE; BLEEDING DISORDER; BONE DENSITY; CASE REPORT; DIARRHEA; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOMETRIOSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HOT FLUSH; HUMAN; INFERTILITY; IRREGULAR BLEEDING; LUTEINIZING HORMONE BLOOD LEVEL; MEDICAL DOCUMENTATION; NAUSEA; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PELVIS PAIN SYNDROME; PREMENOPAUSE; PRIORITY JOURNAL; RIGIDITY; SCORING SYSTEM; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

EID: 61849184923     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.12.002     Document Type: Article

References (14)

1. Amsterdam L.L., Gentry W., Jobanputra S., Wolf M., Rubin S.D., and Bulun S.E. Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil Steril 84 (2005) 300-304
2. Cottreau C.M., Ness R.B., Modugno F., Allen G.O., and Goodman M.T. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. Clin Cancer Res 9 (2003) 5142-5244
3. Takayama K., Zeitoun K., Gunby R.T., Sasano H., Carr B.R., and Bulun S.E. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 69 (1998) 709-713
4. Abbott J.A., Hawe J., Clayton R.D., and Garry R. The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2-5 year follow up. Hum Reprod 18 (2003) 1922-1927
5. Lockhat F.B., Emembolu J.O., and Konje J.C. The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestrogen (levonorgestrel): a 3 year follow-up. Hum Reprod 20 (2005) 789-793
6. The American Fertility Society. Revised American fertility society classification of endometriosis. Fertil Steril 43 (1985) 351
7. Attar E., and Bulun S.E. Aromatase inhibitors: the next generation of therapeutics for endometriosis?. Fertil Steril 85 (2006) 1307-1318
8. Razzi S., Fava A., Sartini A., De Simone S., Ccbellis L., and Petraglia F. Treatment of severe recurrent endometriosis with an aromatase inhibitor in a young ovariectomised women. BJOG 111 (2004) 182-184
9. Santen R.J., Samojlik E., and Wells S.A. Resistance of the ovary to blockade of aromatisation with aminoglutethimide. J Clin Endocrinol Metab 51 (1980) 473-477
10. Wanders H.E., Blossey H.C., and Nagel G.A. Aminoglutethimide in the treatment of premenopausal patients with metastatic breast cancer. Eur J Cancer Clin Oncol 22 (1986) 1371-1374
11. Shippen E.R., and William J.W. Successful treatment of severe endometriosis in two premenopausal women with an aromatase inhibitor. Fertil Steril 81 (2004) 1395-1398
12. Soysal S., Soysal M., Ozer S., Gul N., and Gezgin T. The effects of post surgical administration of goserelin plus anastrazole compared to goserelin alone in patients with severe endometriosis: a prospective randomised trial. Hum Reprod 19 (2004) 160-167
13. Ailawadi R.K., Jobanputra S., Kataria M., Gurates B., and Bulun S.E. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril 81 (2004) 290-296
14. Geisler J., Haynes B., Anker G., et al. Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study. J Clin Oncol 20 (2002) 751-757